EUVC

EUVC | E386 | KFund’s Miguel Arias & Acrobator's Joachim Laqueur in conversation with MiLaboratories's founder

Dec 10, 2024

Join Stanislav Poslavsky, CEO of MiLaboratories, Joachim Laqueur from Acrobator Ventures, and Miguel Arias of KFund as they dive into the dynamic relationship between founders and investors. They discuss the intricate process of fundraising, highlighting the significance of personal connections. The guests explore simplifying complex innovations for broader audiences, touch on the evolution of biotech investments, and humorously critique modern professional imagery. Expect insights into the promising future of MiLaboratories in computational biology and the unique challenges in funding biotech today.

01:00:30

Creator website

Episode guests

Miguel Arias

Joachim Laqueur

Stanislav Poslavsky

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

MiLaboratories, a biotech company founded in 2021, focuses on innovative genomic solutions for academic and pharmaceutical sectors, highlighting its B2B model.

The dynamic collaboration between MiLaboratories' founders and their investors illustrates the vital role of networking and personal connections in securing funding.

MiLaboratories' product strategy, featuring MyXCR and Platforma, aims to democratize genomic data access and enhance research efficiency for non-experts.

Deep dives

Founding and Focus of Mi Laboratories

Mi Laboratories is a B2B biotech company established in 2021, focused on supporting bioinformaticians and biologists in genomic research, particularly within academic and pharmaceutical environments. The company's headquarters is in the U.S., but the bulk of its workforce and R&D capabilities are based in Bilbao, Spain. Since its inception, Mi Laboratories has successfully raised approximately 9 million euros, allowing it to grow to over 20 employees. The company aims to address the increasing need for efficient processing of vast genomic data, which is essential for modern medical advancements such as personalized medicine and new therapeutic developments.

Intro

2min

Navigating Fundraising and Growth in Tech Ventures

17min

Simplifying Complex Innovations

9min

A Lighthearted Critique of Professional Imagery

2min

Navigating Investment and Growth in Health Tech

19min

Innovations in Biotechnology Data Analysis

6min

Building Trust: Founders and Investors

3min

The Promising Future of MiLaboratories in Computational Biology

3min

Welcome to a special episode of the EUVC podcast! This time, we’re experimenting with a new format where we bring together a founder and two of their key investors to uncover the dynamics behind building and scaling a venture-backed company.

In this episode, we’re joined by Stanislav Poslavsky, CEO and Co-Founder of MiLaboratories, a US-based biotech company founded in 2021. Focused on providing innovative solutions for genomic research, MiLaboratories operates on a B2B revenue model, catering to bioinformaticians and biologists in academic and pharmaceutical settings across the US, EU, and UK.

Joachim Laqueur, Founding Partner at Acrobator Ventures, a seed-stage investment firm with €28M in assets under management. Based in the Netherlands, Joachim specializes in backing global startups with a focus on Europe and the US, targeting B2B software and software-enabled hardware.

Miguel Arias, General Partner at KFund, €225M early growth fund, with €650M in assets under management. Based in Spain, Miguel focuses on Series A and B investments across Southern Europe and Latin America, targeting enabling technologies such as AI, IoT, and digital infrastructure.

Together, we explore how MiLaboratories secured its place in their portfolios, the process of building conviction across investment stages, and the unique challenges and opportunities of funding a biotech company in today’s landscape. Expect deep dives into deal-making dynamics, the art of company building, and even a few lighthearted moments that reveal the human side of venture capital.

Go to eu.vc to read the core take-aways.

Chapters:

01:50 Journey: Founding MiLaboratories
02:47 Joachim's Perspective: Investing in MiLaboratories
04:05 The Early Fundraising Challenges
05:30 The Role of COVID in Fundraising
07:45 Miguel's Introduction and Perspective
10:08 Series A Fundraising Experience
15:24 Lessons Learned in Fundraising
19:46 Understanding MiLaboratories' Impact
33:02 The Duality of Business Strategy
33:13 Building a Sustainable Business
34:23 The Power of Open Source
35:48 Conviction in Venture Capital
38:03 Choosing the Right Investors
42:04 The Art of Pricing
45:57 The CEO's Many Hats
49:12 Understanding Platforma and MeXR
53:35 Challenges and Lessons Learned
57:47 The Future of MiLaboratories

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more